Compare IMAX & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | PBH |
|---|---|---|
| Founded | 1967 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 1997 | 2004 |
| Metric | IMAX | PBH |
|---|---|---|
| Price | $51.72 | $49.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $56.58 | ★ $67.80 |
| AVG Volume (30 Days) | ★ 1.1M | 573.1K |
| Earning Date | 10-26-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | 0.35 | ★ 0.61 |
| Revenue | $410,212,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $13.14 | $17.03 |
| Revenue Next Year | $4.97 | $6.06 |
| P/E Ratio | $145.51 | ★ $79.07 |
| Revenue Growth | 16.47 | ★ 36.77 |
| 52 Week Low | $30.74 | $42.62 |
| 52 Week High | $57.73 | $71.07 |
| Indicator | IMAX | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 56.83 |
| Support Level | $50.03 | $48.25 |
| Resistance Level | $55.57 | $49.79 |
| Average True Range (ATR) | 2.12 | 1.22 |
| MACD | -0.48 | 0.48 |
| Stochastic Oscillator | 36.30 | 91.40 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.